Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Thyroid Disorders
What are the treatment options for refractory dysthyroid optic neuropathy in a patient with extensive gastrointestinal history including gastric ulcers and colitis?
Related Questions
In patients with differentiated thyroid cancer, do you consider pathology characteristics not found in the ATA risk stratification guidelines (ie microscopic margins or multifocal cancer) when determining recurrence risk and management?
How do you counsel a patient with hypothyroidism who complains of persistent hypothyroid symptoms despite achieving normal TSH values with levothyroxine?
How do you approach treatment of depression in Graves' Disease?
What factors would lead you to extend the duration of antithyroid drug therapy in a patient with Graves' disease who is clinically euthyroid at 12 months but has risk factors for recurrence?
Would you increase or maintain the same initial dose of methimazole for treatment of hyperthyroidism if symptoms and thyroid tests improve but are not normalized?
What is your approach to treating subacute thyroiditis in a patient presenting with recurrent fevers?
How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?
Are thyroid molecular tests (such as Afirma, ThyroSeq) validated for use on FNA thyroid nodule samples that are not Bethesda class 3-4?
Do you recommend completion thyroidectomy and RAIT in patients found to have unifocal minimally invasive follicular variant of papillary carcinoma on pathology after thyroid lobectomy?
Do you recommend low dose RAI ablation for low risk papillary thyroid cancer with lymphatic invasion alone (no angio-invasion or known nodal involvement)?
